SCHEMBL7100732

SCHEMBL7100732

COc1ccc(Cn2c(=O)c3cc(C(=O)O)ncc3n(C)c2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.51
MAPT P10636 3/20 0.47
MITF O75030 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47
PAX8 Q06710 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PARG Q86W56 1/20 0.46
PDE1B Q01064 5/20 0.46
PDE1A P54750 3/20 0.46
PDE1C Q14123 3/20 0.46
THRB P10828 1/20 0.46
MMP13 P45452 2/20 0.45
SLC22A8 Q8TCC7 2/20 0.45
PIK3CB P42338 2/20 0.45
MTOR P42345 2/20 0.45
PIK3CG P48736 2/20 0.45
KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7017009 0.89 MAPT (0.51) MAPTMITFALDH1A1LMNAPKM
SCHEMBL7103058 0.88 MMP13 (0.47) MAPTALDH1A1LMNAL3MBTL1THRB
SCHEMBL6255569 0.88 MMP13 (0.53) ALDH1A1PKML3MBTL1PARGMMP13
SCHEMBL7018710 0.87 MMP13 (0.46) MAPTALDH1A1LMNAPKML3MBTL1
SCHEMBL7097739 0.87 MMP13 (0.46) MAPTALDH1A1LMNAPKMMAPK1
SCHEMBL6364247 0.86 MMP13 (0.65) MAPTALDH1A1L3MBTL1MMP13SLC22A8
SCHEMBL7018972 0.83 GRIN1 (0.44) PARGMMP13SLC22A8
SCHEMBL6217699 0.83 MMP13 (0.61) PIK3CDMAPTMITFALDH1A1LMNA
SCHEMBL7102299 0.82 GRIN1 (0.44) MAPK1PDE1BMMP13SLC22A8
SCHEMBL6295571 0.82 MMP13 (0.56) MAPTALDH1A1LMNAL3MBTL1MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10150104-B2 Method for preparing aromatization catalysts CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-11 US claimed
US-20170128920-A1 Method for Preparing Aromatization Catalysts CHEVRON PHILLIPS CHEMICAL COMPANY LP 2017-05-11 US claimed
US-6107534-A USING THE IMPROVED ZEOLITE CATALYST IN THE CONVERSION OF HYDROCARBONS, PREFERABLY NON-AROMATIC HYDROCARBONS, TO LOWER OLEFINS (SUCH AS ETHYLENE AND PROPYLENE) AND AROMATIC HYDROCARBONS (SUCH AS BENZENE, TOLUENE, AND XYLENE) PHILLIPS PETROLEUM COMPANY (US) 2000-08-22 US claimed
US-5981417-A TREATING ZEOLITE WITH AN ACID TO FORM ACID-TREATED ZEOLITE, STEAM TREATING ABOVE ZEOLITE, IMPREGNATING BORON COMPONENT AND ZINC COMPONENT WITH STEAM AND ACID TREATED ZEOLITE, AND STEAM TREATING INCORPORATED ZEOLITE PHILLIPS PETROLEUM COMPANY (US) 1999-11-09 US claimed
US-10150104-B2 Method for preparing aromatization catalysts CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-11 US disclosed
US-20170128920-A1 Method for Preparing Aromatization Catalysts CHEVRON PHILLIPS CHEMICAL COMPANY LP 2017-05-11 US disclosed
CN-1944252-A Process for producing boranes AIR PROD & CHEM (US) 2007-04-11 CN disclosed
EP-1368324-A1 QUINAZOLINES AS MMP-13 INHIBITORS Warner-Lambert Company LLC (US) 2003-12-10 EP disclosed
EP-1060021-B1 A COMPOSITION FOR CONVERTING HYDROCARBONS COMPRISING A SILICONIZED ACID-TREATED ZEOLITE CONTAINING ZINC AND BORON AND METHOD OF MAKING SUCH CATALYST CHEVRON PHILLIPS CHEMICAL CO (US) 2003-09-03 EP disclosed
US-20020193377-A1 Quinazolines as MMP-13 inhibitors ANDRIANJARA CHARLES (FR) 2002-12-19 US disclosed
WO-2002064572-A1 QUINAZOLINES AS MMP-13 INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed
EP-1060021-A4 A COMPOSITION FOR CONVERTING HYDROCARBONS COMPRISING A SILICONIZED ACID-TREATED ZEOLITE CONTAINING ZINC AND BORON AND METHOD OF MAKING SUCH CATALYST PHILLIPS PETROLEUM CO (US) 2002-01-30 EP disclosed
EP-1060021-A1 A COMPOSITION FOR CONVERTING HYDROCARBONS COMPRISING A SILICONIZED ACID-TREATED ZEOLITE CONTAINING ZINC AND BORON AND METHOD OF MAKING SUCH CATALYST Phillips Petroleum Company (US) 2000-12-20 EP disclosed
US-6107534-A USING THE IMPROVED ZEOLITE CATALYST IN THE CONVERSION OF HYDROCARBONS, PREFERABLY NON-AROMATIC HYDROCARBONS, TO LOWER OLEFINS (SUCH AS ETHYLENE AND PROPYLENE) AND AROMATIC HYDROCARBONS (SUCH AS BENZENE, TOLUENE, AND XYLENE) PHILLIPS PETROLEUM COMPANY (US) 2000-08-22 US disclosed
US-6080901-A ZEOLITE OR AN ACID LEACHED ZEOLITE CONTAINING BORON, ZINC AND PHOSPHORUS, USED IN THE CONVERSION OF HYDROCARBONS PHILLIPS PETROLEUM COMPANY (US) 2000-06-27 US disclosed
US-5997730-A ACID TREATED ZEOLITE, A BORON COMPONENT AND A ZINC COMPONENT WHEREIN THE MATERIAL IS TREATED WITH A SILYLATING AGENT. PHILLIPS PETROLEUM COMPANY (US) 1999-12-07 US disclosed
US-5981417-A TREATING ZEOLITE WITH AN ACID TO FORM ACID-TREATED ZEOLITE, STEAM TREATING ABOVE ZEOLITE, IMPREGNATING BORON COMPONENT AND ZINC COMPONENT WITH STEAM AND ACID TREATED ZEOLITE, AND STEAM TREATING INCORPORATED ZEOLITE PHILLIPS PETROLEUM COMPANY (US) 1999-11-09 US disclosed
US-5981418-A INCORPORATING INTO A ZEOLITE A LIQUID SOLUTION CONTAINING ZINC COMPONENT, BORON COMPONENT AND PHOSPHORUS COMPONENT, STREAM TREATING THE CATALYST; HYDROREFINING CATALYST PHILLIPS PETROLEUM COMPANY (US) 1999-11-09 US disclosed
WO-1999038614-A1 A COMPOSITION FOR CONVERTING HYDROCARBONS COMPRISING A SILICONIZED ACID-TREATED ZEOLITE CONTAINING ZINC AND BORON AND METHOD OF MAKING SUCH CATALYST PHILLIPS PETROLEUM COMPANY (US) 1999-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193377-A1 Quinazolines as MMP-13 inhibitors MMP13, MMP9, MMP3 PIK3CD 3975/4885MAPT 4823/4885MITF 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.